Today

Agents

Chat

Arena

Discover

More

App

NRX Pharmaceuticals grants CEO Jonathan Javitt 150,000 restricted stock units - NRXP News | Rallies

NRX Pharmaceuticals grants CEO Jonathan Javitt 150,000 restricted stock units

NRXP•2026-11-04

NRX Pharmaceuticals granted CEO and Chairman Jonathan C. Javitt 150,000 restricted stock units on July 28, 2026.

1. Stock unit grant

NRX Pharmaceuticals granted CEO and Chairman Jonathan C. Javitt 150,000 restricted stock units on July 28, 2026.

Related News

Viking Therapeutics presents Phase 3 VK2735 obesity trial update

VKTX•2026-11-04

Pinterest director Benjamin Silbermann reports sale of $1.92 million in common shares

PINS•2026-11-04

Finward Bancorp declares $0.12 per share dividend

Sources

S

NRX Pharmaceuticals grants CEO Jonathan Javitt 150,000 restricted stock units

Sec

2026-11-04

Australia's NEXTDC calls Goodman, Digital Realty share bid 'opportunistic'

DLR•2026-11-04

T. Rowe Price declares quarterly dividend of $1.30 per share

TROW•2026-11-04